425
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Screening Circular RNA Related to Chemotherapeutic Resistance in Osteosarcoma by RNA Sequencing

, , , , , & show all
Pages 1327-1346 | Received 08 Feb 2018, Accepted 10 Apr 2018, Published online: 07 Sep 2018

References

  • Moore DD , LuuHH . Osteosarcoma . Cancer Treat. Res.162 , 65 – 92 ( 2014 ).
  • Biazzo A , De PaolisM . Multidisciplinary approach to osteosarcoma . Acta Orthop. Belg.82 ( 4 ), 690 – 698 ( 2016 ).
  • Botter SM , NeriD , FuchsB . Recent advances in osteosarcoma . Curr. Opin. Pharmacol.16 , 15 – 23 ( 2014 ).
  • Ferrari S , SerraM . An update on chemotherapy for osteosarcoma . Expert Opin. Pharmacother.16 ( 18 ), 2727 – 2736 ( 2015 ).
  • Sun M , KrausWL . From discovery to function: the expanding roles of long noncoding RNAs in physiology and disease . Endocr. Rev.36 ( 1 ), 25 – 64 ( 2015 ).
  • Martens-Uzunova ES , OlvedyM , JensterG . Beyond microRNA–novel RNAs derived from small non-coding RNA and their implication in cancer . Cancer Lett.340 ( 2 ), 201 – 211 ( 2013 ).
  • Beermann J , PiccoliMT , ViereckJ , ThumT . Non-coding RNAs in development and disease: background, mechanisms, and therapeutic approaches . Physiol. Rev.96 ( 4 ), 1297 – 1325 ( 2016 ).
  • Qu S , YangX , LiXet al. Circular RNA: a new star of noncoding RNAs . Cancer Lett.365 ( 2 ), 141 – 148 ( 2015 ).
  • Meng S , ZhouH , FengZet al. CircRNA: functions and properties of a novel potential biomarker for cancer . Mol. Cancer16 ( 1 ), 94 ( 2017 ).
  • Li J , YangJ , ZhouPet al. Circular RNAs in cancer: novel insights into origins, properties, functions and implications . Am. J. Cancer Res.5 ( 2 ), 472 – 480 ( 2015 ).
  • Lasda E , ParkerR . Circular RNAs: diversity of form and function . RNA (New York, NY)20 ( 12 ), 1829 – 1842 ( 2014 ).
  • Chen LL , YangL . Regulation of circRNA biogenesis . RNA Biol.12 ( 4 ), 381 – 388 ( 2015 ).
  • Salzman J . Circular RNA expression: its potential regulation and function . Trends Genet.32 ( 5 ), 309 – 316 ( 2016 ).
  • Chen I , ChenCY , ChuangTJ . Biogenesis, identification, and function of exonic circular RNAs . Wiley Interdiscip. Rev. RNA6 ( 5 ), 563 – 579 ( 2015 ).
  • Barrett SP , SalzmanJ . Circular RNAs: analysis, expression and potential functions . Development143 ( 11 ), 1838 – 1847 ( 2016 ).
  • Zhang H , WangG , DingCet al. Increased circular RNA UBAP2 acts as a sponge of miR-143 to promote osteosarcoma progression . Oncotarget8 ( 37 ), 61687 – 61697 ( 2017 ).
  • Li JF , SongYZ . Circular RNA GLI2 promotes osteosarcoma cell proliferation, migration, and invasion by targeting miR-125b-5p . Tumour Biol.39 ( 7 ), 1010428317709991 ( 2017 ).
  • Song YZ , LiJF . Circular RNA hsa_circ_0001564 regulates osteosarcoma proliferation and apoptosis by acting miRNA sponge . Biochem. Biophys. Res. Commun.495 ( 3 ), 2369 – 2375 ( 2018 ).
  • Oda Y , MatsumotoY , HarimayaK , IwamotoY , TsuneyoshiM . Establishment of new multidrug-resistant human osteosarcoma cell lines . Oncol. Rep.7 ( 4 ), 859 – 866 ( 2000 ).
  • Lourda M , TrougakosIP , GonosES . Development of resistance to chemotherapeutic drugs in human osteosarcoma cell lines largely depends on up-regulation of Clusterin/Apolipoprotein J . Int. J. Cancer120 ( 3 ), 611 – 622 ( 2007 ).
  • Yang C , YangS , WoodKBet al. Multidrug resistant osteosarcoma cell lines exhibit deficiency of GADD45alpha expression . Apoptosis14 ( 1 ), 124 – 133 ( 2009 ).
  • Zhang CL , ZhuKP , MaXL . Antisense lncRNA FOXC2-AS1 promotes doxorubicin resistance in osteosarcoma by increasing the expression of FOXC2 . Cancer Lett.396 , 66 – 75 ( 2017 ).
  • Kun-Peng Z , Xiao-LongM , Chun-LinZ . LncRNA FENDRR sensitizes doxorubicin-resistance of osteosarcoma cells through down-regulating ABCB1 and ABCC1 . Oncotarget8 ( 42 ), 71881 – 71893 ( 2017 ).
  • Xu M , JinH , XuCX , BiWZ , WangY . MiR-34c inhibits osteosarcoma metastasis and chemoresistance . Med. Oncol.31 ( 6 ), 972 ( 2014 ).
  • Chou AJ , GorlickR . Chemotherapy resistance in osteosarcoma: current challenges and future directions . Expert Rev. Anticancer Ther.6 ( 7 ), 1075 – 1085 ( 2006 ).
  • Yan GN , LvYF , GuoQN . Advances in osteosarcoma stem cell research and opportunities for novel therapeutic targets . Cancer Lett.370 ( 2 ), 268 – 274 ( 2016 ).
  • He J , XieQ , XuH , LiJ , LiY . Circular RNAs and cancer . Cancer Lett.396 , 138 – 144 ( 2017 ).
  • Liu W , ZhangJ , ZouCet al. Microarray expression profile and functional analysis of circular RNAs in osteosarcoma . Cell Physiol. Biochem.43 ( 3 ), 969 – 985 ( 2017 ).
  • Deng N , LiL , GaoJet al. Hsa_circ_0009910 promotes carcinogenesis by promoting the expression of miR-449a target IL6R in osteosarcoma . Biochem. Biophys. Res. Commun.495 ( 1 ), 189 – 196 ( 2018 ).
  • Jin H , JinX , ZhangH , WangW . Circular RNA hsa-circ-0016347 promotes proliferation, invasion and metastasis of osteosarcoma cells . Oncotarget8 ( 15 ), 25571 – 25581 ( 2017 ).
  • Song YD , LiDD , GuanY , WangYL , ZhengJ . miR-214 modulates cisplatin sensitivity of osteosarcoma cells through regulation of anaerobic glycolysis . Cell. Mol. Biol. (Noisy-le-Grand, France)63 ( 9 ), 75 – 79 ( 2017 ).
  • Bansal S , BerkM , AlkhouriN , PartrickDA , FungJJ , FeldsteinA . Stearoyl-CoA desaturase plays an important role in proliferation and chemoresistance in human hepatocellular carcinoma . J. Surg. Res.186 ( 1 ), 29 – 38 ( 2014 ).
  • Perez J , BardinC , RigalC , AnthonyB , RousseauR , DutourA . Anti-MDR1 siRNA restores chemosensitivity in chemoresistant breast carcinoma and osteosarcoma cell lines . Anticancer Res.31 ( 9 ), 2813 – 2820 ( 2011 ).
  • Zhan M , QuQ , WangG , ZhouH . Let-7c sensitizes acquired cisplatin-resistant A549 cells by targeting ABCC2 and Bcl-XL . Die Pharm.68 ( 12 ), 955 – 961 ( 2013 ).
  • Yue B , MaJF , YaoG , YangMD , ChengH , LiuGY . Knockdown of neuropilin-1 suppresses invasion, angiogenesis, and increases the chemosensitivity to doxorubicin in osteosarcoma cells - an in vitro study . Eur. Rev. Med. Pharmacol. Sci.18 ( 12 ), 1735 – 1741 ( 2014 ).
  • Rong D , SunH , LiZet al. An emerging function of circRNA-miRNAs-mRNA axis in human diseases . Oncotarget8 ( 42 ), 73271 – 73281 ( 2017 ).
  • Ebbesen KK , KjemsJ , HansenTB . Circular RNAs: identification, biogenesis and function . Biochim. Biophys. Acta1859 ( 1 ), 163 – 168 ( 2016 ).
  • Hansen TB , KjemsJ , DamgaardCK . Circular RNA and miR-7 in cancer . Cancer Res.73 ( 18 ), 5609 – 5612 ( 2013 ).
  • Zheng Q , BaoC , GuoWet al. Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs . Nat. Comm.7 , 11215 ( 2016 ).
  • He R , LiuP , XieXet al. circGFRA1 and GFRA1 act as ceRNAs in triple negative breast cancer by regulating miR-34a . J. Exp. Clin. Cancer Res.36 ( 1 ), 145 ( 2017 ).
  • Han D , LiJ , WangHet al. Circular RNA circMTO1 acts as the sponge of microRNA-9 to suppress hepatocellular carcinoma progression . Hepatology (Baltimore)66 ( 4 ), 1151 – 1164 ( 2017 ).
  • Tian J , XuYY , LiL , HaoQ . MiR-490-3p sensitizes ovarian cancer cells to cisplatin by directly targeting ABCC2 . Am. J. Transl. Res.9 ( 3 ), 1127 – 1138 ( 2017 ).
  • Chen S , ChenX , XiuYL , SunKX , ZongZH , ZhaoY . microRNA 490-3P enhances the drug-resistance of human ovarian cancer cells . J. Ovarian Res.7 , 84 ( 2014 ).
  • Li Q , LiZ , WeiSet al. Overexpression of miR-584-5p inhibits proliferation and induces apoptosis by targeting WW domain-containing E3 ubiquitin protein ligase 1 in gastric cancer . J. Exp. Clin. Cancer Res.36 ( 1 ), 59 ( 2017 ).
  • Xiang X , MeiH , QuHet al. miRNA-584-5p exerts tumor suppressive functions in human neuroblastoma through repressing transcription of matrix metalloproteinase 14 . Biochim. Biophys. Acta1852 ( 9 ), 1743 – 1754 ( 2015 ).
  • Li G , WuX , QianWet al. CCAR1 5′ UTR as a natural miRancer of miR-1254 overrides tamoxifen resistance . Cell Res.26 ( 6 ), 655 – 673 ( 2016 ).
  • Zhao Y , ZhangCL , ZengBF , WuXS , GaoTT , OdaY . Enhanced chemosensitivity of drug-resistant osteosarcoma cells by lentivirus-mediated Bcl-2 silencing . Biochem. Biophys. Res. Comm.390 ( 3 ), 642 – 647 ( 2009 ).
  • Zhang C , ZhaoY , ZengB . Enhanced chemosensitivity by simultaneously inhibiting cell cycle progression and promoting apoptosis of drug-resistant osteosarcoma MG63/DXR cells by targeting Cyclin D1 and Bcl-2 . Cancer Biomark.12 ( 4 ), 155 – 167 ( 2012 ).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.